世界の粘液線毛クリアランス&機能不全治療市場インサイト及び予測(薬品、手術、粘液クリアランス装置、その他)

◆英語タイトル:Global Mucociliary Clearance and Dysfunction Treatment Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09256)◆商品コード:QY22JLX09256
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、粘液線毛クリアランス&機能不全治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に粘液線毛クリアランス&機能不全治療の世界市場のxxx%を占める「薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
粘液線毛クリアランス&機能不全治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの粘液線毛クリアランス&機能不全治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

粘液線毛クリアランス&機能不全治療のグローバル主要企業には、Vortran Medical Technology、Smiths Group、Monaghan、Hill-Rom Services、Allergan、Novartis、AstraZeneca、Merck、Regeneron Pharmaceuticals、Abbott、F. Hoffmann-La Roche、Cadila Pharmaceuticals、Eisai、Cipla、Glenmark Pharmaceuticals Limited、Vertical Pharmaceuticals、TORAY INDUSTRIES、Pfizerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

粘液線毛クリアランス&機能不全治療市場は、種類と用途によって区分されます。世界の粘液線毛クリアランス&機能不全治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
薬品、手術、粘液クリアランス装置、その他

【用途別セグメント】
病院、専門クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 粘液線毛クリアランス&機能不全治療製品概要
- 種類別市場(薬品、手術、粘液クリアランス装置、その他)
- 用途別市場(病院、専門クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の粘液線毛クリアランス&機能不全治療販売量予測2017-2028
- 世界の粘液線毛クリアランス&機能不全治療売上予測2017-2028
- 粘液線毛クリアランス&機能不全治療の地域別販売量
- 粘液線毛クリアランス&機能不全治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別粘液線毛クリアランス&機能不全治療販売量
- 主要メーカー別粘液線毛クリアランス&機能不全治療売上
- 主要メーカー別粘液線毛クリアランス&機能不全治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(薬品、手術、粘液クリアランス装置、その他)
- 粘液線毛クリアランス&機能不全治療の種類別販売量
- 粘液線毛クリアランス&機能不全治療の種類別売上
- 粘液線毛クリアランス&機能不全治療の種類別価格
・用途別市場規模(病院、専門クリニック、その他)
- 粘液線毛クリアランス&機能不全治療の用途別販売量
- 粘液線毛クリアランス&機能不全治療の用途別売上
- 粘液線毛クリアランス&機能不全治療の用途別価格
・北米市場
- 北米の粘液線毛クリアランス&機能不全治療市場規模(種類別、用途別)
- 主要国別の粘液線毛クリアランス&機能不全治療市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの粘液線毛クリアランス&機能不全治療市場規模(種類別、用途別)
- 主要国別の粘液線毛クリアランス&機能不全治療市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の粘液線毛クリアランス&機能不全治療市場規模(種類別、用途別)
- 主要国別の粘液線毛クリアランス&機能不全治療市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の粘液線毛クリアランス&機能不全治療市場規模(種類別、用途別)
- 主要国別の粘液線毛クリアランス&機能不全治療市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの粘液線毛クリアランス&機能不全治療市場規模(種類別、用途別)
- 主要国別の粘液線毛クリアランス&機能不全治療市場規模(トルコ、サウジアラビア)
・企業情報
Vortran Medical Technology、Smiths Group、Monaghan、Hill-Rom Services、Allergan、Novartis、AstraZeneca、Merck、Regeneron Pharmaceuticals、Abbott、F. Hoffmann-La Roche、Cadila Pharmaceuticals、Eisai、Cipla、Glenmark Pharmaceuticals Limited、Vertical Pharmaceuticals、TORAY INDUSTRIES、Pfizer
・産業チェーン及び販売チャネル分析
- 粘液線毛クリアランス&機能不全治療の産業チェーン分析
- 粘液線毛クリアランス&機能不全治療の原材料
- 粘液線毛クリアランス&機能不全治療の生産プロセス
- 粘液線毛クリアランス&機能不全治療の販売及びマーケティング
- 粘液線毛クリアランス&機能不全治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 粘液線毛クリアランス&機能不全治療の産業動向
- 粘液線毛クリアランス&機能不全治療のマーケットドライバー
- 粘液線毛クリアランス&機能不全治療の課題
- 粘液線毛クリアランス&機能不全治療の阻害要因
・主な調査結果

Mucociliary dysfunction is a common sign of chronic obstructive pulmonary disease. Mucociliary clearance is a well-known innate defense system against microbes and irritants inhaled through the nose. The Saccharine Test in the sino-nasal system can be used to assess mucociliary clearance. The therapy for mucociliary clearance generally includes proteolytic enzymes to reduce mucus viscosity, vibrations for improving ciliary beat frequency, irrigation with Locke-Ringer’s solution for cilia frequency, glucosteroids and surfactants.
Market Analysis and Insights: Global Mucociliary Clearance and Dysfunction Treatment Market
The global Mucociliary Clearance and Dysfunction Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Medications accounting for % of the Mucociliary Clearance and Dysfunction Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Mucociliary Clearance and Dysfunction Treatment market size is valued at US$ million in 2021, while the North America and Europe Mucociliary Clearance and Dysfunction Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mucociliary Clearance and Dysfunction Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mucociliary Clearance and Dysfunction Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mucociliary Clearance and Dysfunction Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mucociliary Clearance and Dysfunction Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mucociliary Clearance and Dysfunction Treatment market.
Global Mucociliary Clearance and Dysfunction Treatment Scope and Market Size
Mucociliary Clearance and Dysfunction Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mucociliary Clearance and Dysfunction Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medications
Surgery
Mucus Clearance Device
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Company
Vortran Medical Technology
Smiths Group
Monaghan
Hill-Rom Services
Allergan
Novartis
AstraZeneca
Merck
Regeneron Pharmaceuticals
Abbott
F. Hoffmann-La Roche
Cadila Pharmaceuticals
Eisai
Cipla
Glenmark Pharmaceuticals Limited
Vertical Pharmaceuticals
TORAY INDUSTRIES
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medications
1.2.3 Surgery
1.2.4 Mucus Clearance Device
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mucociliary Clearance and Dysfunction Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucociliary Clearance and Dysfunction Treatment Market Perspective (2017-2028)
2.2 Mucociliary Clearance and Dysfunction Treatment Growth Trends by Region
2.2.1 Mucociliary Clearance and Dysfunction Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Region (2017-2022)
2.2.3 Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Region (2023-2028)
2.3 Mucociliary Clearance and Dysfunction Treatment Market Dynamics
2.3.1 Mucociliary Clearance and Dysfunction Treatment Industry Trends
2.3.2 Mucociliary Clearance and Dysfunction Treatment Market Drivers
2.3.3 Mucociliary Clearance and Dysfunction Treatment Market Challenges
2.3.4 Mucociliary Clearance and Dysfunction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucociliary Clearance and Dysfunction Treatment Players by Revenue
3.1.1 Global Top Mucociliary Clearance and Dysfunction Treatment Players by Revenue (2017-2022)
3.1.2 Global Mucociliary Clearance and Dysfunction Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Mucociliary Clearance and Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mucociliary Clearance and Dysfunction Treatment Revenue
3.4 Global Mucociliary Clearance and Dysfunction Treatment Market Concentration Ratio
3.4.1 Global Mucociliary Clearance and Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucociliary Clearance and Dysfunction Treatment Revenue in 2021
3.5 Mucociliary Clearance and Dysfunction Treatment Key Players Head office and Area Served
3.6 Key Players Mucociliary Clearance and Dysfunction Treatment Product Solution and Service
3.7 Date of Enter into Mucociliary Clearance and Dysfunction Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucociliary Clearance and Dysfunction Treatment Breakdown Data by Type
4.1 Global Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Type (2017-2022)
4.2 Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Type (2023-2028)
5 Mucociliary Clearance and Dysfunction Treatment Breakdown Data by Application
5.1 Global Mucociliary Clearance and Dysfunction Treatment Historic Market Size by Application (2017-2022)
5.2 Global Mucociliary Clearance and Dysfunction Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
6.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type
6.2.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
6.2.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
6.2.3 North America Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
6.3 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application
6.3.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
6.3.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
6.3.3 North America Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
6.4 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country
6.4.1 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
6.4.2 North America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
7.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type
7.2.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
7.2.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
7.2.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
7.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application
7.3.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
7.3.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
7.3.3 Europe Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
7.4 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country
7.4.1 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
7.4.2 Europe Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
8.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type
8.2.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application
8.3.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region
8.4.1 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mucociliary Clearance and Dysfunction Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
9.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type
9.2.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
9.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application
9.3.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
9.4 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country
9.4.1 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size (2017-2028)
10.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type
10.2.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application
10.3.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country
10.4.1 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mucociliary Clearance and Dysfunction Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vortran Medical Technology
11.1.1 Vortran Medical Technology Company Details
11.1.2 Vortran Medical Technology Business Overview
11.1.3 Vortran Medical Technology Mucociliary Clearance and Dysfunction Treatment Introduction
11.1.4 Vortran Medical Technology Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.1.5 Vortran Medical Technology Recent Developments
11.2 Smiths Group
11.2.1 Smiths Group Company Details
11.2.2 Smiths Group Business Overview
11.2.3 Smiths Group Mucociliary Clearance and Dysfunction Treatment Introduction
11.2.4 Smiths Group Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.2.5 Smiths Group Recent Developments
11.3 Monaghan
11.3.1 Monaghan Company Details
11.3.2 Monaghan Business Overview
11.3.3 Monaghan Mucociliary Clearance and Dysfunction Treatment Introduction
11.3.4 Monaghan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.3.5 Monaghan Recent Developments
11.4 Hill-Rom Services
11.4.1 Hill-Rom Services Company Details
11.4.2 Hill-Rom Services Business Overview
11.4.3 Hill-Rom Services Mucociliary Clearance and Dysfunction Treatment Introduction
11.4.4 Hill-Rom Services Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.4.5 Hill-Rom Services Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Mucociliary Clearance and Dysfunction Treatment Introduction
11.5.4 Allergan Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Mucociliary Clearance and Dysfunction Treatment Introduction
11.6.4 Novartis Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Mucociliary Clearance and Dysfunction Treatment Introduction
11.7.4 AstraZeneca Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Mucociliary Clearance and Dysfunction Treatment Introduction
11.8.4 Merck Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.9.5 Regeneron Pharmaceuticals Recent Developments
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Mucociliary Clearance and Dysfunction Treatment Introduction
11.10.4 Abbott Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.10.5 Abbott Recent Developments
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Company Details
11.11.2 F. Hoffmann-La Roche Business Overview
11.11.3 F. Hoffmann-La Roche Mucociliary Clearance and Dysfunction Treatment Introduction
11.11.4 F. Hoffmann-La Roche Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.11.5 F. Hoffmann-La Roche Recent Developments
11.12 Cadila Pharmaceuticals
11.12.1 Cadila Pharmaceuticals Company Details
11.12.2 Cadila Pharmaceuticals Business Overview
11.12.3 Cadila Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.12.4 Cadila Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.12.5 Cadila Pharmaceuticals Recent Developments
11.13 Eisai
11.13.1 Eisai Company Details
11.13.2 Eisai Business Overview
11.13.3 Eisai Mucociliary Clearance and Dysfunction Treatment Introduction
11.13.4 Eisai Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.13.5 Eisai Recent Developments
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Mucociliary Clearance and Dysfunction Treatment Introduction
11.14.4 Cipla Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.14.5 Cipla Recent Developments
11.15 Glenmark Pharmaceuticals Limited
11.15.1 Glenmark Pharmaceuticals Limited Company Details
11.15.2 Glenmark Pharmaceuticals Limited Business Overview
11.15.3 Glenmark Pharmaceuticals Limited Mucociliary Clearance and Dysfunction Treatment Introduction
11.15.4 Glenmark Pharmaceuticals Limited Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.15.5 Glenmark Pharmaceuticals Limited Recent Developments
11.16 Vertical Pharmaceuticals
11.16.1 Vertical Pharmaceuticals Company Details
11.16.2 Vertical Pharmaceuticals Business Overview
11.16.3 Vertical Pharmaceuticals Mucociliary Clearance and Dysfunction Treatment Introduction
11.16.4 Vertical Pharmaceuticals Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.16.5 Vertical Pharmaceuticals Recent Developments
11.17 TORAY INDUSTRIES
11.17.1 TORAY INDUSTRIES Company Details
11.17.2 TORAY INDUSTRIES Business Overview
11.17.3 TORAY INDUSTRIES Mucociliary Clearance and Dysfunction Treatment Introduction
11.17.4 TORAY INDUSTRIES Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.17.5 TORAY INDUSTRIES Recent Developments
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Mucociliary Clearance and Dysfunction Treatment Introduction
11.18.4 Pfizer Revenue in Mucociliary Clearance and Dysfunction Treatment Business (2017-2022)
11.18.5 Pfizer Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の粘液線毛クリアランス&機能不全治療市場インサイト及び予測(薬品、手術、粘液クリアランス装置、その他)(Global Mucociliary Clearance and Dysfunction Treatment Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。